Sangrix restates interim financials after correcting share classification and warrant dividend errors
Sangrix filed a Form 6-K/A restating interim financial statements for the six months ended Dec. 31, 2025. Restatement deemed material under SEC Staff Accounting Bulletin No. 99. Reclassified certain redeemable Class A ordinary shares from permanent equity to mezzanine equity, shifting US$ 4.2 million within equity. Rec